# Dexamethasone Therapy in VLBW Infants at Risk of CLD

> **NCT00011362** · PHASE3 · COMPLETED · sponsor: **NICHD Neonatal Research Network** · enrollment: 371 (actual)

## Conditions studied

- Infant, Newborn
- Infant, Low Birth Weight
- Infant, Small for Gestational Age
- Infant, Premature
- Bronchopulmonary Dysplasia

## Interventions

- **DRUG:** Dexamethasone Early
- **DRUG:** Dexamethasone Late

## Key facts

- **NCT ID:** NCT00011362
- **Lead sponsor:** NICHD Neonatal Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1992-09
- **Primary completion:** 1994-01
- **Final completion:** 1994-04
- **Target enrollment:** 371 (ACTUAL)
- **Last updated:** 2019-03-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00011362

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00011362, "Dexamethasone Therapy in VLBW Infants at Risk of CLD". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00011362. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*